Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rallybio
Biotech
Rallybio reigns in preclinical, Monopar pivots to radiopharma
Rallybio and Monopar are respectively stopping preclinical investment and pivoting to radiopharmaceuticals to stretch limited resources.
Nick Paul Taylor
May 9, 2024 10:13am
J&J funds Rallybio in risk-busting rare pregnancy disease pact
Apr 10, 2024 4:00pm
Rallybio drops 45% of workforce to extend cash runway into 2026
Feb 6, 2024 9:45am
Abbvie's president adds COO title—Chutes & Ladders
Jun 30, 2023 9:30am
Rallybio reassembles behind fetal blood disorder med 2.0
Mar 6, 2023 11:48am
Rallybio revs up antibody discovery activities in AbCellera pact
Dec 1, 2022 9:30am
